🇺🇸 Antipsychotic in United States

135 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Completed Suicide — 28 reports (20.74%)
  2. Toxicity To Various Agents — 14 reports (10.37%)
  3. Convulsion — 13 reports (9.63%)
  4. Drug Toxicity — 13 reports (9.63%)
  5. Tachycardia — 13 reports (9.63%)
  6. Multiple Drug Overdose — 12 reports (8.89%)
  7. Cardiac Arrest — 11 reports (8.15%)
  8. Overdose — 11 reports (8.15%)
  9. Somnolence — 11 reports (8.15%)
  10. Drug Ineffective — 9 reports (6.67%)

Source database →

Other Neuroscience approved in United States

Frequently asked questions

Is Antipsychotic approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Antipsychotic in United States?

Réseau de Santé Vitalité Health Network is the originator. The local marketing authorisation holder may differ — check the official source linked above.